FBR

NVIDIA Corporation (NASDAQ: NVDA) reported a blowout fourth quarter earnings report Thursday, but was it good enough to turn Wall Street's skeptics to bulls? Here's a look at how some Wall Street analysts reacted. Oppenheimer: NVDA Surpassed High Expectations Oppenheimer's...

Analysts at B. Riley FBR initiated coverage of Novavax, Inc. (NASDAQ: NVAX) on Jan. 5 with a Buy rating and $2.25 price target. Just five days later, the firm turned uber-bullish on the stock. The Analyst George Zavoico maintains a Buy rating on Novavax's stock with a 12-month price target...

On both an absolute and relative basis, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)’s pipeline is a winner. “We have conviction that Alnylam’s hATTR franchise will dominate that of Ionis,” FBR analyst Madhu Kumar wrote in a Monday note. Ionis Pharmaceuticals Inc (NASDAQ:...

Duluth Holdings Inc (NASDAQ: DLTH)'s second-quarter earnings report prompted analyst at FBR Capital Markets to reiterate a bullish stance on the stock. Analyst Eric Beder maintains a Buy rating on Duluth Holdings' stock with an unchanged $26 price target after the company's earnings not...

Analysts at FBR have high expectations for Netflix, Inc. (NASDAQ: NFLX) heading into the company's second-quarter earnings report but aren't recommending investors buy the stock. The firm's Barton Crockett maintains a Market Perform rating on Netflix's stock with an unchanged $145 price target. One...

FBR's Barton Crockett added shares of Pandora Media Inc (NYSE: P) to the firm's "Alpha Generator list" while maintaining an Outperform rating and $11 price target for three key reasons. First, Pandora is better positioned to perform in the streaming music space following a $480 million strategic...

Analysts at FBR & Co. upgraded shares of Metlife Inc (NYSE: MET) as the stock's underperformance versus its peers since the start of 2017 has now created a compelling buying opportunity. FBR's Randy Binner upgraded MetLife's stock from Market Perform to Outperform with a price target boosted...

FBR & Co. analyst Susan Anderson downgraded shares of Under Armour Inc (NYSE: UAA) from Market Perform to Underperform with a price target slashed from $20 to $14. Anderson's downgrade follows recent checks, proprietary surveys and current trends that all point to continued sales and margin...

Chris Meekins, an analyst at FBR, was a guest on CNBC's "Halftime Report" segment on Wednesday and offered three reasons why pharmaceutical investors should brush off President-elect Donald Trump's comments that he is "going to bring down drug prices." 3 Reasons First, Meekins argued what is more...

Media and entertainment company Walt Disney Co (NYSE: DIS) is due to release its fiscal year fourth-quarter results after the market close. Analysts, on average, expect the company to report earnings of $1.16 per share, down from $1.20 per share last year, on revenues of $13.52 billion, almost...

Zions Bancorp’s (NASDAQ: ZION) ROTCE could improve from 5.3 percent in 1Q15 to about 9 percent over the next 12 to 18 months, backed by cost-cutting efforts, the sale of CDOs, and the redeployment of capital, FBR’s Paul J. Miller said in a report. He upgraded the rating for the...

FBR & Co. started National Commerce Corp (NASDAQ: NCOM) with a Market Perform rating and price target of $27 per share, saying that although the bank's asset quality has been good, equity returns have trailed peer averages. FBR says National Commerce shares will rise after it grows...